Have you been diagnosed with cancer after undergoing a hysterectomy or procedure to remove fibroids?
If so, you probably have a lot of questions.
- Did my procedure cause my health problems?
- Can I claim compensation?
- How do I find out if I have a case? Will it cost me anything?
Burg Simpson is currently investigating legal claims against leading manufacturers of power morcellators, including the Gynecare Morcellex™ manufactured by Ethicon. Women who have received a diagnosis for cancer after undergoing a hysterectomy or fibroid removal surgery may be entitled to compensation.
Did my procedure cause my health problems? Can a power morcellator spread cancer?
Power morcellators are widely used in minimally invasive (laparoscopic) hysterectomies and uterine fibroid removal procedures. These small-bladed devices allow surgeons to cut the uterus or fibroid tissues into small parts, for easy removal through a laparoscopic tube inserted through a small incision in the patient’s abdomen.
For women who may have previously undiagnosed cancer or sarcoma, there is a serious risk of the device spreading cancerous cells inside the body.
Recent medical studies published in the Journal of the American Medical Association in March 2014, and the much publicized story of 40 year old Boston doctor Amy Reed, who developed cancer after undergoing a hysterectomy using a power morcellator, has prompted the medical community, federal regulators, and lawyers to consider whether these devices pose a serious health risk to women.
In its first safety warning, the FDA said, ”Based on an analysis of currently available data, the FDA has determined that approximately one in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma (leiomyosarcoma). If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.”
On November 24, 2014, the FDA issued a second safety communication, stating, “If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s long-term survival.”
The second warning goes on to say,“The FDA is warning against the use of laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy for treatment of fibroids.”
Today there are more than a dozen power morcellator devices on the market, but shortly after the FDA issued its warning in April, Ethicon360, a division of Johnson & Johnson and the largest manufacturer of power morcellators, took the decision to suspend sales of its device. A coincidence?
Our attorneys have been appointed by federal courts to serve in leadership positions in numerous other high-profile dangerous drug lawsuits, including those involving defective birth control pills, blood thinners and metal-on-metal hip replacements.
We have the resources, results and reputation you need in a law firm.
To find out if you have a case, call us now at 800-737-9055. Contact us today for a confidential, free, no-obligation consultation.
Gynecare Morcellex™ is a trademark of Ethicon Endo-Surgery, Inc.